The United States and Zambia signed a health financing agreement in Lusaka on Thursday after stripping out the specimen-sharing and patient-data clauses that had stalled the pact, the Associated Press reported. The US State Department put the deal’s value at $2.49 billion over five years, with the US contributing $1.52 billion and Zambia investing $975 million into its health system, somewhat less than the $3.6 billion mooted by Zambian officials earlier in the week.
The mineral angle was the fight that mattered for this beat. Foreign Minister Mulambo Haimbe had criticized an early US attempt to link health funding to American economic interests through a separate arrangement on critical minerals. Health Minister Elijah Muchima told reporters this week there is no mention of critical minerals in the signed agreement, and he said he was unaware of any separate negotiations on mineral access. Data sharing is now limited to what is required to monitor and evaluate US-funded health programs, and the clause that would have required Zambia to transfer patient specimens to Washington on request is gone.
Zambia is Africa’s second-largest copper producer and the test case for Washington’s new bilateral aid architecture after the dismantling of USAID. The original terms had demanded access to patient records and biological samples within five days, plus provisions letting private US firms profit from research, according to reporting on the stalled talks. Lusaka’s successful pushback, and the explicit uncoupling of health funding from copper concessions, sets a precedent that Ghana and Zimbabwe, which have rejected similar deals over data-sovereignty concerns, will watch closely. Zambia’s mineral endowment, including its copper and emerging cobalt and manganese positions, will now be negotiated separately, on terms Lusaka has signaled it will not trade for health dollars.